Acutaas Chemicals Limited — Others, 02-05-2025: Statement of deviation(s) or variation(s) under Reg. 32

Ami Organics Limited confirms no deviation in the use of ₹99.10 Cr raised from its Preferential Issue. By the quarter ended March 31, 2025, ₹45.51 Cr was deployed for capital expenditure in electrolyte additives and related business, and ₹22.10 Cr for general corporate purposes, totaling ₹67.61 Cr as planned. The audit committee and auditors reviewed these utilizations without any concerns, highlighting disciplined fund management that supports the company’s growth strategy.